LucasAI vs Nabla (2026)

AI Health Index verifiedOctober 12, 2026
Verdict

LucasAI and Nabla both sell ambient notes with E/M coding suggestions that an individual clinician can start online, and LucasAI's comparison page names Nabla as an alternative. Nabla brings independent trial evidence; LucasAI brings a wider set of billing tools. Nabla drafts structured notes, suggests E/M levels and ICD-10 diagnoses, and integrates with Epic, athenahealth, Oracle Health, NextGen and Greenway, placing vitals and diagnoses into chart fields. A UCLA randomized trial published in NEJM AI found it cut time in notes by 9.5 percent against usual care. Clinicians pay $119 a month after a 30 day trial, and Nabla supports more than 35 languages. LucasAI's plans run from $39.99 to $999 a month, with coding confirmed by the clinician or coder, HCC and V28 analytics, prior authorization support, wound care DME ordering and voice agents. LucasAI suits a practice that wants documentation tied to coding and authorization work; Nabla suits one that wants trial backed documentation with structured EHR write back.

The case for LucasAI
  • Plans starting below $70 a month, with a resident plan at $39.99.
  • MCC and CC analytics alongside HCC and V28 on higher plans.
  • Prior authorization and DME ordering tools for practices that file their own payer paperwork.
  • Voice agents for intake and outreach and sub acute care support on its top plan.
The case for Nabla
  • An independent randomized trial at UCLA, published in NEJM AI, showing less time in notes.
  • Two way integration with Epic, athenahealth, Oracle Health, NextGen and Greenway, filing vitals and diagnoses into chart fields.
  • More than 35 supported languages.
  • A model card in the Coalition for Health AI format available on request.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. LucasAI and Nabla are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact LucasAI Nabla
Primary category Ambient Scribes Ambient Scribes
Founded Not recorded 2018
Headquarters Miami, Florida, United States Paris, France
Website lucashealth.ai nabla.com
Attribute Matrix

Side by Side

Select any grade to read the note behind it.

Axis
L
LucasAI
N
Nabla
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Citable Summaries

Each vendor in one paragraph

Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached.

LucasAI

LucasAI drafts notes from visits held in English, Spanish or a mix of both and returns them by the end of the encounter. Its plans reach further into billing than note writing, with HCC, V28, MCC and CC analytics, an audit mitigation assistant and guideline based prompts from Case Guardian on the higher tiers.

Source: AI Health Index, October 2026

Nabla

Nabla sells an ambient AI assistant that drafts structured clinical notes, with dictation and E/M coding suggestions, to health systems, medical groups and individual clinicians. It integrates with major EHRs and places vitals, diagnoses and patient instructions into chart fields.

Source: AI Health Index, October 2026

FAQ

Questions buyers ask

Has either been tested in a trial?

Nabla was one arm of a UCLA randomized trial in NEJM AI that found a 9.5 percent cut in time in notes against usual care. LucasAI reports internal data across more than 1,200 providers and physician testimonials, with no published study. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 12, 2026. No vendor pays for placement.

What does an individual clinician pay?

Nabla charges an individual $119 a month after a 30 day free trial, with group rates on request. LucasAI publishes plans from $39.99 to $999 a month with a trial of 30 days or 10 notes. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 12, 2026. No vendor pays for placement.

Which languages does each handle?

Nabla supports more than 35 languages, from Spanish and French to Arabic dialects, Haitian Creole and Khmer. LucasAI handles visits that switch between English and Spanish, and its DME ordering interface runs in both languages. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 12, 2026. No vendor pays for placement.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.

Disclosure

Lucas Health Corporation, a Miami company with physicians as chief executive and chief medical officer, makes LucasAI.